Universidad del País Vasco/Euskal Herriko Unibertsitatea-ko ikertzaileekin lankidetzan egindako argitalpenak (8)

2024

  1. Initial response and 12-month outcomes after commencing dexamethasone or vascular endothelial growth factor inhibitors for retinal vein occlusion in the FRB registry

    Scientific Reports, Vol. 14, Núm. 1

2023

  1. Predictors of stoppage and recurrence of choroidal neovascularization with a Treat- Extend-Stop protocol: 4-year follow-up

    Journal Francais d'Ophtalmologie, Vol. 46, Núm. 10, pp. 1204-1211

2022

  1. Factores de riesgo asociados al error refractivo residual tras cirugía de catarata en práctica clínica. Estudio observacional retrospectivo

    Archivos de la Sociedad Española de Oftalmologia, Vol. 97, Núm. 3, pp. 140-148

  2. Prediction Error Stabilization and Long-Term Standard Results with a Monofocal Intraocular Lens

    Vision (Switzerland), Vol. 6, Núm. 1

  3. Short-term effectiveness prognostic factors after dexamethasone intravitreal implant in macular edema due to retinal vein occlusion

    European Journal of Ophthalmology, Vol. 32, Núm. 3, pp. 1671-1679

2021

  1. Safety and efficacy of bilateral simultaneous XEN implant surgery: a pilot study

    International Ophthalmology, Vol. 41, Núm. 3, pp. 859-866

2019

  1. Author Correction: A new approach based on targeted pooled DNA sequencing identifies novel mutations in patients with Inherited Retinal Dystrophies (Scientific Reports, (2018), 8, 1, (15457), 10.1038/s41598-018-33810-3)

    Scientific Reports

2017

  1. Dabrafenib for cutaneous melanoma infiltrating the vitreous: regression of metastasis and occurrence of uveitis as a secondary effect

    Journal of Ophthalmic Inflammation and Infection